CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 815,377 enrolled
Drug / intervention
Initiation of beclometasone via the Easibreathe device plus salbutamol via the Easibreathe device +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01313585
NCT01313585N/ACompleted
CompareCT.gov

Retrospective, Real-life Observational Evaluation of the Effectiveness of Mixed Maintenance and Reliever Inhaler Types in Patients in the Management of Asthma in a Representative UK Primary Care Population

Research in Real-Life Ltd·observational·Posted Mar 14, 2011·Updated Mar 14, 2011

In Brief

An observational study evaluating Initiation of beclometasone via the Easibreathe device plus salbutamol via the Easibreathe device, Initiation of beclometasone via the Easibreathe device plus salbutamol via and MDI device, and 2 other interventions for Asthma. Completed, enrolled 815,377 participants across 1 site.

Detailed Summary

This study will compare the absolute and relative effectiveness of asthma management in patients on inhaled corticosteroid (ICS) maintenance therapy as Easi-breathe® (EB) - beclometasone dipropionate (BDP) breath-actuated inhaler (BAI) - and as-needed (prn) reliever medication (short-acting beta2-agonist \[SABA\] therapy) via either a BAI (i.e. Easi-breathe® \[EB\] salbutamol) or via a pressurised metered dose inhaler (MDI) (e.g. MDI salbutamol).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited Kingdom
CollaboratorsTeva Branded Pharmaceutical Products R&D, Inc.

Timeline

N/ACompletedFinished
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 14, 2011
Enrollment StartJan 1, 1991
Primary CompletionJun 1, 2007
Study CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 16.4 yearsPosted 15.3 years ago

Interventions

Initiation of beclometasone via the Easibreathe device plus salbutamol via the Easibreathe devicedrug

Initiation of beclometasone via the Easibreathe device plus salbutamol via and MDI devicedrug

Increase of beclometasone via the Easibreathe device plus salbutamol via the Easibreathe devicedrug

Increase of beclometasone via the Easibreathe device plus salbutamol via an MDIdrug